Bartlett & Co. LLC cut its stake in CVS Health Corporation (NYSE:CVS) by 0.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 468,889 shares of the pharmacy operator’s stock after selling 4,352 shares during the period. CVS Health Corporation accounts for 1.7% of Bartlett & Co. LLC’s portfolio, making the stock its 19th largest position. Bartlett & Co. LLC’s holdings in CVS Health Corporation were worth $37,727,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Mercer Capital Advisers Inc. purchased a new position in CVS Health Corporation during the first quarter valued at $118,000. Gemmer Asset Management LLC increased its position in CVS Health Corporation by 15.3% in the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares during the period. D Orazio & Associates Inc. increased its position in CVS Health Corporation by 34.5% in the fourth quarter. D Orazio & Associates Inc. now owns 1,560 shares of the pharmacy operator’s stock valued at $123,000 after buying an additional 400 shares during the period. Sowell Financial Services LLC purchased a new position in CVS Health Corporation during the fourth quarter valued at $140,000. Finally, Patriot Financial Group Insurance Agency LLC purchased a new position in CVS Health Corporation during the fourth quarter valued at $156,000. 81.92% of the stock is currently owned by institutional investors and hedge funds.

Shares of CVS Health Corporation (CVS) traded up 1.47% during mid-day trading on Monday, hitting $79.12. 4,600,840 shares of the stock were exchanged. The firm has a 50-day moving average price of $78.75 and a 200 day moving average price of $79.09. The company has a market capitalization of $80.61 billion, a PE ratio of 16.50 and a beta of 0.91. CVS Health Corporation has a 12-month low of $69.30 and a 12-month high of $98.44.

The company also recently announced a quarterly dividend, which was paid on Thursday, August 3rd. Investors of record on Monday, July 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.00 annualized dividend and a dividend yield of 2.53%. CVS Health Corporation’s dividend payout ratio is presently 41.67%.

ILLEGAL ACTIVITY WARNING: “Bartlett & Co. LLC Cuts Stake in CVS Health Corporation (CVS)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/08/07/bartlett-co-llc-decreases-position-in-cvs-health-corporation-cvs-updated.html.

Several research analysts have recently weighed in on CVS shares. Leerink Swann set a $90.00 target price on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, June 27th. Vetr downgraded shares of CVS Health Corporation from a “strong-buy” rating to a “buy” rating and set a $88.97 target price on the stock. in a research report on Monday, June 12th. Tigress Financial started coverage on shares of CVS Health Corporation in a research report on Thursday, April 27th. They issued a “buy” rating on the stock. Guggenheim reissued a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Finally, ValuEngine downgraded shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $92.20.

In related news, EVP Helena Foulkes sold 20,332 shares of the firm’s stock in a transaction on Monday, June 19th. The shares were sold at an average price of $76.98, for a total value of $1,565,157.36. Following the completion of the transaction, the executive vice president now directly owns 59,300 shares of the company’s stock, valued at $4,564,914. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction on Monday, June 12th. The shares were sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the completion of the transaction, the chief financial officer now directly owns 176,983 shares of the company’s stock, valued at $14,158,640. The disclosure for this sale can be found here. Insiders sold 271,175 shares of company stock valued at $21,632,597 over the last three months. 0.61% of the stock is owned by company insiders.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.